- Home
- UEC vs VRNA Comparison
UEC vs VRNA Comparison
Compare UEC & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEC
- VRNA
- Stock Information
- Founded
- UEC 2003
- VRNA 2005
- Country
- UEC United States
- VRNA United Kingdom
- Employees
- UEC N/A
- VRNA N/A
- Industry
- UEC Other Metals and Minerals
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- UEC Basic Materials
- VRNA Health Care
- Exchange
- UEC Nasdaq
- VRNA Nasdaq
- Market Cap
- UEC 3.0B
- VRNA 3.4B
- IPO Year
- UEC N/A
- VRNA 2017
- Fundamental
- Price
- UEC $5.68
- VRNA $67.96
- Analyst Decision
- UEC Strong Buy
- VRNA Strong Buy
- Analyst Count
- UEC 2
- VRNA 7
- Target Price
- UEC $10.63
- VRNA $57.14
- AVG Volume (30 Days)
- UEC 6.7M
- VRNA 1.3M
- Earning Date
- UEC 03-10-2025
- VRNA 02-27-2025
- Dividend Yield
- UEC N/A
- VRNA N/A
- EPS Growth
- UEC N/A
- VRNA N/A
- EPS
- UEC N/A
- VRNA N/A
- Revenue
- UEC $17,203,000.00
- VRNA $5,624,000.00
- Revenue This Year
- UEC $60,962.50
- VRNA N/A
- Revenue Next Year
- UEC $34.61
- VRNA $571.44
- P/E Ratio
- UEC N/A
- VRNA N/A
- Revenue Growth
- UEC N/A
- VRNA 1127.95
- 52 Week Low
- UEC $4.06
- VRNA $11.39
- 52 Week High
- UEC $8.93
- VRNA $68.64
- Technical
- Relative Strength Index (RSI)
- UEC 28.88
- VRNA 76.88
- Support Level
- UEC $5.84
- VRNA $62.24
- Resistance Level
- UEC $7.20
- VRNA $65.50
- Average True Range (ATR)
- UEC 0.34
- VRNA 2.78
- MACD
- UEC -0.12
- VRNA 0.22
- Stochastic Oscillator
- UEC 3.79
- VRNA 94.86
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.